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Abstract-- The ability of coenzyme Q to inhibit lipid peroxidation in intact animals as well as in mitochondrial. 
submitochondrial, and microsomal systems has been tested. Rats fed coenzyme Q prior to being treated with 
carbon tetrachloride or while being treated with ethanol excrete less thiobarbituric acid-reacting material in the 
urine than such rats not fed coenzyme Q. Liver homogenates, mitochondria, and microsomes isolated from rats 
treated with carbon tetrachloride and ethanol catalyze lipid peroxidation at rates which exceed those from animals 
also fed coenzyme Q. The rate of lipid peroxidation catalyzed by submitochondrial particles isolated from hearts 
of young, old, and endurance trained elderly rats was inversely proportional to the coenzyme Q content of the 
submitochondrial preparation in assays in which succinate was employed to reduce the endogenous coenzyme Q. 
Reduced, but not oxidized, coenzyme Q inhibited lipid peroxidation catalyzed by rat liver microsomal preparations. 
These results provide additional evidence in support of an antioxidant role for coenzyme Q. 
Keywords--Coenzyme Q, Ubiquinone, Lipid peroxidation, Ethanol, Carbon tetrachloride, Antioxidation, Mi- 
tochondria, Microsomes, Free radical 
INTRODUCTION 
Evolution of organisms to the aerobic life style has 
required that mechanisms be selected to protect cells 
from the damaging effects of reactive oxygen free rad- 
ical species produced during oxidative reactions. Of 
the many enzymatic and molecular devices which have 
been demonstrated to provide protection from free rad- 
ical damage, perhaps the most controversial is the role 
of coenzyme Q (otherwise known as ubiquinone) in 
free radical production and as an antioxidant. In ad- 
dition to its function in the mitochondrial electron 
transfer chain, ~ reduced coenzyme Q influences the 
rate of electron flux through the succinate dehydro- 
genase, 2 NADH dehydrogenase, 3 and cytochrome b-  
c~ 4 complexes. CoQ also appears to be involved in the 
establishment of an inner mitochondrial transmem- 
brane protonmotive gradient, the "protonmotive Q 
cyc le , "  resulting in the conservation of energy released 
by oxidation-reduction reactions of the electron trans- 
fer chain)  CoQ has been implicated as the electron 
transfer chain member responsible for superoxide rad- 
ical production as well as serving as an inhibitor of 
superoxide radical production during electron transfer 
chain activity, subjects which have been reviewed. 6-9 
The experiments reported herein were designed to 
study the effect of CoQ on the extent of lipid peroxi- 
dation both in vivo and in vitro employing treatments 
such as ethanol and carbon tetrachloride known to re- 
sult in free radical damage. 
MATERIALS AND METHODS 
Animals 
All animals used were male Sprague-Dawley rats 
obtained from Charles River Breeding Laboratories, 
Portage, Michigan, except for those used in the ex- 
periments on microsomal lipid peroxidation which 
were from the University of Stockholm Research An- 
imal Quarters. Aged rats were obtained as retired 
breeders at 9 months of  age and rested until 25 months 
of age except in the ease of  exercise-trained rats which 
were run 5 days each week for 21 weeks until 25 
months old as described previously. 1° They were 
housed singly in wire bottom cages in a room segre- 
gated from other species and maintained at 22°C on a 
12 hour light-dark cycle. All animals received Purina 
Laboratory Rat chow and water ad libitum. To study 
the effect of  chronic ethanol administration, 2.5% 
ethanol (w/v in water) was substituted for drinking 
water for 30 days. CoQ~ 0 dissolved in olive oil was 
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administered orally to rats daily (3 mg/kg/day)  for 14 
days during the latter portion of the experimental pe- 
riod. Rat urine was collected using a home-made stain- 
less steel screen-funnel device. 
The effect of carbon tetrachloride was studied by 
injecting (i.p.) 1 ml CC14/kg body weight as a 25% 
solution in mineral oil to rats fasted overnight (17 
hours). Controls were treated with mineral oil. Rats 
were killed by decapitation 24 hours after treatment. 
Materials 
Carbon tetrachloride was obtained from Aldrich 
Chemical Co., Milwaukee, Wisconsin. CoQ~0 was a 
generous gift of  Eisai Co. Ltd., Tokyo, and in Stock- 
holm, was " b o r r o w e d "  from Gustav Dallner 's cache 
with the help of Peter L6w. Reduced CoQ solutions 
were prepared immediately prior to use by reduction 
in ethanol with NaBH4, extraction with petroleum ether 
(BR 40-60°) ,  drying in vacuo under N2 and dissolving 
the colorless residue in 2% cardiolipin in ethanol. The 
solution was maintained under N2 and protected from 
light. Oxidized CoQ used in microsomal experiments 
was treated identically except for the reduction by 
NaBH4. Cardiolipin, NADH, NADPH, ADP, 2-thio- 
barbituric acid, menadione and ascorbate were ob- 
tained from Sigma Chemical Co., St. Louis, Missouri. 
Preparations and assays 
Rat liver microsomes were prepared according to 
Ernster et al. ' l  Rat liver mitocochondria were isolated 
according to Johnson and Lardy ~2 and heart SMPs 
prepared essentially as previously described. ~3 Lipid 
peroxidation was assayed in vitro by measuring ma- 
londialdehyde formation and oxygen consumption ac- 
cording to Ernster and Nordenbrand. ~4 Urinary ma- 
londialdehyde was measured according to Draper et 
al. 15 Protein was determined with a biuret procedure. 16 
Rat urine, together with cage washings, were collected 
over a 24 hour period and lyophilized to dryness. The 
residue was dissolved in 1 ml of water. One ml of a 
saturated thiobarbituric acid solution was added, the 
pH adjusted to 3.0 with HCI, and the mixture heated 
in a boiling water bath for 30 minutes and cooled. After 
centrifugation, the absorbtivity of the clear solution 
was determined at 535 rim. An extinction coefficient 
of 1.56 x 105 M - l c m  -~ was used ~4 to calculate the 
MDA content. CoQ was extracted and its concentra- 
tion determined spectrophotometrically. ~7 NADH-sup- 
ported lipid peroxidation catalyzed by rat heart SMPs 
was assayed at 37 ° by incubating 1 mg of SMP protein 
in 1 ml of a solution containing 4 nmol rotenone, 2 mM 
ADP, 0.2 mM FeCI3, 50 mM TrisHCl, pH 7.4 and, 
when present to reduce endogenous CoQ, 10 mM suc- 
cinate. The reaction was initiated by the addition of 
1 mM NADH and terminated after 10 minutes by the 
addition of 50 uL of 100% TCA. MDA formation was 
determined according to Ernster and Nordenbrand.t~ 
Whenever possible, all assays were performed in 
triplicate. 
RESULTS 
Although MDA produced as a product of lipid per- 
oxidation in vivo, to a large extent, is metabolized to 
CO,, about 10% of orally administered MDA is ex- 
creted in the urine which normally contains MDA in 
an acid hydrolizable form.18 MDA, as an indicator of 
lipid peroxidation in vivo ~5'18 was measured in urine 
from rats pretreated with CoQ and to which CCL or 
ethanol was administered (Table 1). CoQ administra- 
tion tended to decrease urinary MDA in control ani- 
mals. The large increase in urinary MDA which 
resulted from CC14 administration was lowered to a 
significant degree in animals pretreated with CoQ (Ta- 
ble 1). Although ethanol was a less potent stimulator 
of lipid peroxidation compared to CCL, the increase 
in urinary MDA as a result of ethanol consumption was 
also diminished by pretreatment with CoQ (Table 1). 
As is well established, ~9 treatment of rats with CCL 
or ethanol results in an increase in products of lipid 
peroxidation (MDA) in liver and its particulate frac- 
tions. The data in Table 2 indicate that treatment of 
rats with oral administration of CoQ reduced the en- 
dogenous control levels of TBA-reacting material, in- 
dicative of peroxidized lipids, in the liver homogenate 
and its mitochondrial and microsomal fractions. 
Administration of CCL resulted in a large increase in 
MDA formation after 24 hours in the three tissue frac- 
tions studied (Table 2). Ethanol treatment also resulted 
in an increase in all fractions, but to a lesser degree. 
Prior treatment with CoQ gave rise to a lower concen- 
tration of TBA-reacting material in the homogenate, 
and mitochondrial and microsomal fractions in both 
CCL- and ethanol-treated rats (Table 2). 
Mitochondrial CoQ concentrations have been ma- 
Table 1. TBA-Reacting Material in 24 Hour Urine Samples of Rats 
Treated with CCL, Ethanol, and CoQ. Data as Mean - SE 
Urine MDA 
# Treatment n (ug/24 hrs) Comparison P = 
I Control 6 0.92 +- 0.045 
2 CoQ 6 0.62 -- 0.037 2 vs. 1 NS 
3 CCL 5 4.88 -- 0.32 3 vs. 1 <0,01 
4 CCL + CoQ 6 1.46 + 0.18 4 vs~ 3 <0.01 
5 EtOH 7 2.42 -+ 0.22 5 vs, I <0~05 
6 EtOH + CoQ 6 0.81 -+- 0.07 6 vs. 5 <0.05 
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Table 2. TBA-Reacting Material (MDA) in Liver Fractions from Rats Treated with CCh, Ethanol, and CoQ. Data as mean +-- SE 
Fraction 
# Group (n) Homog.' Comps P Mito." Comp.' P Mic." Comps P 
1 Control (8) 86 • 4 - -  - 8.2 - 0.3 - -  - 5.4 - 0.3 - -  - 
2 CoQ (6) 13 +- 1 2 & I <.001 3.7 + 0.3 2 & 1 <.01 3.2 - 0.1 2 & I <.02 
3 CCI, (8) 766 ± 14 3 & I <.001 28.3 ± 2.8 3 & 1 <.05 10.7 -+ 0.8 3 & I <.05 
4 CCI, + CoQ (7) 465 ± 13 4 & 3 <.001 I1.1 -+ 0.7 4 & 3 <.05 6.5 + 0.4 4 & 3 <.1 
5 EtOH (6) 188 --- 7 5 & ! <.001 19.8 + 2.2 5 & 1 <.05 8.4 - 0.4 5 & I <.05 
6 EtOH + CoQ (5) 15 +-. 2 6 & 5 <.001 4.6 - 0.4 6 & 5 <.02 3.4 -+ 0.5 6 & 5 <.01 
~nmol MDA/gram liver;, bnmol MDA/mg protein; ~Cornp.; Groups compared statistically. 
nipulated by extraction with organic solvents and rein- 
corporated to varying degrees with sonic treatment. 
However, we have used physiological regulation of 
tissue CoQ content by endurance training to in- 
crease ~°'2° and aging to lower 21'22 cardiac CoQ levels 
in order to study the influence of differing endogenous 
CoQ levels on lipid peroxidation catalyzed by heart 
SMPs. The data in Table 3 indicate that IMM CoQ 
concentrations decreased 30% between 3 and 25 
months of age in sedentary animals while a regimen 
of moderate running 5 days/week for 5 months in- 
creased the CoQ concentration 41% compared to el- 
derly sedentary animals. In addition, small differences 
were observed in the rate of NADH-supported lipid 
peroxidation catalyzed by SMPs isolated from hearts 
of these three groups of animals. The differences were 
in the direction of changes in overall tissue respiratory 
activity reported under these circumstances previ- 
ously. 1°'23'24 The addition of succinate to reduce en- 
dogenous CoQ resulted in inhibition of lipid per- 
oxidation in each case. The extent of inhibition by 
succinate was in direct proportion to the endogenous 
CoQ content of the SMPs, being greatest in particles 
from 25 month old trained and 3 month old sedentary 
rats and lowest in SMPs prepared from hearts of 25 
month old sedentary animals. 
As microsomal membranes have been reported to 
contain appreciable quantities of CoQ, 25.26 the effect 
of the oxidoreduction state of CoQ added to isolated 
rat liver microsomal preparations has been studied (Ta- 
ble 4). The addition of CoQ in the fully oxidized state 
stimulated oxygen consumption from NADPH via 
ADP-Fe 2÷ but did not affect the extent of MDA for- 
mation compared to the EtOH-CL solvent control. Ox- 
idized CoQ addition was observed to have a weak 
inhibitory effect occasionally. The inclusion of 150 aM 
and 300 aM CoQH2 inhibited MDA formation to 20% 
and 4% respectively of the EtOH-CL control level. The 
presence of oxidized CoQ did not interfere with the 
antioxidative activity of the reduced form. Inhibition 
of oxygen consumption and MDA formation by 
CoQ~0H2 over the concentration range 15-300 aM 
gave an apparent Ki, or IC~0 of 57 aM. The IC50 values 
determined for two other antioxidant quinones, men- 
adione and vitamin K5 (4-amino-2-methyl- l-naphthol), 
were 20 nM for menadione and 37 nM for vitamin K5. 
The IC5o that we have obtained for menadione is 
slightly lower than 37 nM reported by Talcott et al. 27 
DISCUSSION 
Incomplete understanding of the functional rationale 
for the relatively high molar ratio of CoQ to other 
mitochondrial electron transfer chain components, 2s 
and the role of CoQ found in intracellular membranes 
in addition to the IMM, 29 has led to speculation 2°'2~ 
about other functions for CoQ in addition to those in 
energy conservation and related reactions. Since the 
initial studies suggesting an antioxidant role for 
CoQ, 3°-32 evidence has continued to accumulate from 
Table 3. The Effect of Endurance Training and Age on CoQ Concentrations in and Lipid Peroxidation Catalyzed by Rat Heart 
SMPs. Data are mean _ SE 
# SMPs from n CoQ' Comp b P Addn. MDA formed' Comp b P 
1 Sed-25 b 7 2.4 --- .10 6.48 -+ .19 2 & 1 <.001 
2 Sed-25 Succinate 2.79 ± .  17 
3 Tr-25 8 3.4 --- .10 3 & 1 <.05 7.27 + .21 4 & 3 <.001 
4 Tr-25 Succinate 1.02 ± . 11 
5 Sed-3 8 3.6 -+ .14 5 & I <.05 6.83 +- .18 6 & 5 <.001 
6 Sed-3 5 & 3 >.5 Succinate 1.37 -+ .26 
*nmols/mg protein, bAbbreviations: Comp: groups compared statistically; Seal-25, Tr-25, Seal-3:25 month old sedentary and trained, and 3 month 
old sedentary rats respectively. 
300 R. E. BEYER 
Table 4. ~ Effect of Redox State of Coenzyme Q on NADPH. ADP-Fe -~ ~-supported Lipid 
Peroxidation Catalyzed by Rat Liver Microsomes 
Oxygen Consumption MDA formed 
Concentration (natoms/min/ 
Additions (pM) mg protein) % of C ~ (nmol) % of C ~ 
EtOH-CL b - -  224 100 5.87 100 
CoQt0 150 320 143 5.71 97 
CoQ~oH2 150 59 26 1.19 20 
CoQioH2 300 31 14 0.26 4 
CoQi0 + CoQioHz 150 + 75 97 43 2.01 34 
~Too few experiments (3) performed for meaningful statistical analysis; data are from a typical 
experiment, each of which was internally consistent, bAbbreviations: C, control: CL, cardiolipin. 
experiments at levels ranging from intact animals to 
recontituted systems in vitro supporting the concept of 
CoQ as a membrane protective device against free rad- 
ical damage. 6-9 The results reported herein are from 
experiments designed to test the hypothesis that CoQ 
may provide such protection, from the intact animal 
to the subcellular level, under experimental conditions 
reported by others to result in oxidative stress. 
Ethanol has long been known to produce tissue dam- 
age resulting from superoxide, hydrogen peroxide, and 
hydroxyl radical production 33-3g and ensuing lipid per- 
oxidation. 39"4° Ethanol has been shown to alter micro- 
somal metabolism 3s and to depress mitochondrial ox- 
idative phosphorylationf -44 possibly via oxygen 
radical-mediated protein damage 45 to the IMM Fo " F~ 
ATP synthetase. 46 In addition, the antioxidant vitamin 
A has been reported to ameliorate testicular lipid per- 
oxidation and atrophy that occurs with chronic ethanol 
feeding.47 In a similar, but more potent manner, carbon 
tetrachloride administration has been shown to result 
in pathology ~9 resulting from free radical formation 48 
and subsequent lipid peroxidation: 9 
The results of the experiments on alcohol and carbon 
tetrachloride intoxication support the concept that 
CoQ, administered to the intact animal or added in 
vitro, is able to diminish the rate of free radical-me- 
diated lipid peroxidation in vivo or in subcellular sys- 
tems isolated from animals so treated. In addition, the 
antioxidative capacity of CoQH2 has been demon- 
strated by its ability to inhibit lipid peroxidation in an 
isolated microsomal system. These data are consistant 
with reports that CoQ has a protective role in CC14 
toxicity, 5°'5~ and that CoQ is able to protect against 
adriamycin-induced mitochondrial respiratory chain in- 
activation and lipid peroxidation) 2 
Our demonstration that physiologically manipulated 
endogenous mitochondrial CoQ levels are related to 
the degree of lipid peroxidation catalyzed by SMPs 
derived therefrom, is consistant with results of similar 
experiments on lipid peroxidation in mitochondria 52 
and SMPs 53 chemically depleted of and reconstituted 
with CoQ. The data in Table 3 above also confirm 
those of Takeshige et al. 53 and others 54 on the ability 
of succinate to decrease the rate of lipid peroxidation 
in mitochondrial systems and to lower the subsequent 
membrane damage. The direct relationship between the 
inhibition by reduced CoQ in microsomal membranes 
(Table 4) as well as the protective effect of succinate 
in the submitochondrial system (Table 3) supports the 
contention that it is the reduced state of CoQ which is 
able to react as an antioxidant. The strong antioxidant 
effect of CoQ in the microsomal system would also 
suggest a role for CoQ in endoplasmic reticular mem- 
branes, a question of function which is unresolved: 5 
Discovery of the existence of the semiquinone form 
of CoQ during electron transfer ~6 has led to speculation 
that CoQ may be the source of free radicals produced 
during electron transfer chain activity. 57's8 The find- 
ing 53 (Table 3) that rotenone, a potent inhibitor of 
NADH-CoQ reductase which blocks the flow of elec- 
trons from NADH to CoQ, does not inhibit free radical 
production from NADH, strongly suggests that the 
superoxide radical produced during electron transfer 
is generated from flavin radicals 59 or nonheme-iron- 
sulfur protein 6° prior to the reduction of CoQ. Addi- 
tional support for mitochondrial components other than 
CoQ as generators of the superoxide radical has ap- 
peared.6~.62 
The mechanism by which CoQH2 acts as an antiox- 
idant remains unresolved. Among the possibilities is 
the reaction of CoQH: with ADP-perferryl ion as sug- 
gested by Svingen et a1.63: 
ADP-Fe 3+ - 02 ~ + CoQH2 ; 
ADP-Fe 2÷ + H20~. + CoQ 
H E 0  2 would be removed by catalase, peroxidase, or 
glutathione peroxidase. Alternatively, reduced CoQ 
could react with superoxide directly as a free radical 
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quencher:  
2 O2 ~ + CoQH2 ) H20: + 02 + CoQ 
and thus interfere with the ini t iat ion of lipid peroxi- 
dation. Furthermore,  CoQH2 might react with lipid free 
radicals or lipid peroxide free radicals: 
2 L. + CoQH2 ) 2 LH + CoQ 
2LOO" + CoQH2 . , 2 L O O H  + CoQ 
and thus interfere with the propagation reaction of lipid 
peroxidation.  
The role of free radicals and natural  antioxidants in 
longevity and disease 64-66 is of obvious concern.  Tissue 
CoQ concentrat ions fall with age 2~'22 and,  together with 
alpha-tocopherol ,  ~7 are elevated in physically active 
individuals.l°'2°'21 It would appear reasonable that in- 
vestigation of the ant ioxidant  role of CoQ in the in- 
crease in longevi ty in exercised rats 6s'69 and active 
humansf l  °m as well as the low incidence of breast can- 
cer and cancer of the female reproductive system in 
former college athletes, ~233 deserves serious attention. 
The efficacy of CoQ in the treatment and prevent ion 
of a number  of pathological states has been well doc- 
umentedf l  4-79 
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ABBREVIATIONS 
C o Q - - c o e n z y m e  Q 
C o Q H 2 - - r e d u c e d  c o e n z y m e  Q 
S M P - - s u b m i t o c h o n d r i a l  pa r t i c le  
T B A w t h i o b a r b i t u r i c  ac id  
I M M - - i n n e r  m i t o c h o n d r i a l  m e m b r a n e  
C L - - c a r d i o l i p i n  
M D A - - m a l o n d i a l d e h y d e .  
